| P50 | author | Longtao Wu | Q57062695 |
| | Nassir Mansour | Q61074814 |
| P2093 | author name string | Wei Zhang | |
| | Ralph R Weichselbaum | |
| | Irina V Balyasnikova | |
| | Bakhtiar Yamini | |
| | Clayton D Crawley | |
| | David J Voce | |
| | Giovanna M Bernal | |
| | Gustavo F Larsen | |
| | Kirk E Cahill | |
| | Luis Nunez | |
| | Ruben Spretz | |
| P2860 | cites work | Expression of the Bcl-3 proto-oncogene suppresses p53 activation | Q24300022 |
| | MGMT gene silencing and benefit from temozolomide in glioblastoma | Q27824832 |
| | Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 |
| | Transcription initiation sites and promoter structure of the human TRAIL-R3 gene | Q28213507 |
| | Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein | Q28216526 |
| | An antagonist decoy receptor and a death domain-containing receptor for TRAIL | Q28245153 |
| | Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors | Q28245164 |
| | The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers | Q28260566 |
| | Signals from within: the DNA-damage-induced NF-kappaB response | Q28291658 |
| | Apoptosis control by death and decoy receptors | Q33597389 |
| | Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1. | Q33862991 |
| | Death and decoy receptors and p53-mediated apoptosis. | Q33913737 |
| | Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B | Q34305414 |
| | Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials | Q34429383 |
| | Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL | Q34650759 |
| | RNAi-based therapeutics-current status, challenges and prospects | Q34659612 |
| | New regulators of NF-kappaB in inflammation | Q34858737 |
| | p50 (NF-κB1) is an effector protein in the cytotoxic response to DNA methylation damage | Q35619335 |
| | Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy | Q36558024 |
| | DNA damage-induced cytotoxicity is mediated by the cooperative interaction of phospho-NF-κB p50 and a single nucleotide in the κB-site | Q36559233 |
| | Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway | Q36637883 |
| | Bcl-3, a multifaceted modulator of NF-kappaB-mediated gene transcription | Q37323455 |
| | Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma. | Q37412139 |
| | The therapeutic potential of TRAIL receptor signalling in cancer cells. | Q37962655 |
| | Death receptor-4 (DR4) expression is regulated by transcription factor NF-kappaB in response to etoposide treatment | Q39990806 |
| | P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells | Q40001770 |
| | Inhibition of nuclear factor-kappaB activity by temozolomide involves O6-methylguanine induced inhibition of p65 DNA binding | Q40105449 |
| | Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli | Q40312088 |
| | Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity | Q40361004 |
| | Molecular cytogenetic analysis of chromosomes 1 and 19 in glioma cell lines | Q40411187 |
| | Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma | Q40514765 |
| | Apoptotic signaling in response to a single type of DNA lesion, O(6)-methylguanine. | Q40569371 |
| | Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. | Q40571746 |
| | Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) decoy receptor TRAIL-R3 is up-regulated by p53 in breast tumor cells through a mechanism involving an intronic p53-binding site. | Q40615752 |
| | CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death | Q40616862 |
| | Transfection and expression of human O6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents | Q46067039 |
| | Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine | Q48479768 |
| | Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB | Q64381570 |
| | Cytogenetic and molecular changes in chronic B-cell leukemia | Q69404848 |
| | Rel/NF-kappaB transcription factors protect against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by up-regulating the TRAIL decoy receptor DcR1 | Q73877654 |
| | Protein phosphorylation as a key mechanism for the regulation of BCL-3 activity | Q81179906 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2039-2048 | |
| P577 | publication date | 2015-03-25 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Decoy Receptor DcR1 Is Induced in a p50/Bcl3-Dependent Manner and Attenuates the Efficacy of Temozolomide | |
| P478 | volume | 75 | |